- Home
- QLGN vs VERO Comparison
QLGN vs VERO Comparison
Compare QLGN & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- VERO
- Stock Information
- Founded
- QLGN 1996
- VERO N/A
- Country
- QLGN United States
- VERO Canada
- Employees
- QLGN N/A
- VERO N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- QLGN Health Care
- VERO Health Care
- Exchange
- QLGN Nasdaq
- VERO Nasdaq
- Market Cap
- QLGN 2.4M
- VERO 2.4M
- IPO Year
- QLGN N/A
- VERO N/A
- Fundamental
- Price
- QLGN $3.32
- VERO $2.41
- Analyst Decision
- QLGN
- VERO
- Analyst Count
- QLGN 0
- VERO 0
- Target Price
- QLGN N/A
- VERO N/A
- AVG Volume (30 Days)
- QLGN 111.5K
- VERO 68.1K
- Earning Date
- QLGN 04-15-2025
- VERO 03-31-2025
- Dividend Yield
- QLGN N/A
- VERO N/A
- EPS Growth
- QLGN N/A
- VERO N/A
- EPS
- QLGN N/A
- VERO N/A
- Revenue
- QLGN N/A
- VERO $64,833,000.00
- Revenue This Year
- QLGN N/A
- VERO N/A
- Revenue Next Year
- QLGN N/A
- VERO $4.95
- P/E Ratio
- QLGN N/A
- VERO N/A
- Revenue Growth
- QLGN N/A
- VERO N/A
- 52 Week Low
- QLGN $2.96
- VERO $2.20
- 52 Week High
- QLGN $29.45
- VERO $17.49
- Technical
- Relative Strength Index (RSI)
- QLGN 44.88
- VERO 39.24
- Support Level
- QLGN $3.06
- VERO $2.20
- Resistance Level
- QLGN $3.78
- VERO $4.03
- Average True Range (ATR)
- QLGN 0.28
- VERO 0.46
- MACD
- QLGN 0.03
- VERO -0.05
- Stochastic Oscillator
- QLGN 19.80
- VERO 4.42
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.